Skip to content

Balloon Inflation Time for Esophageal Strictures (BITES): A Randomized Multi-Center Study

Balloon Inflation Time for Esophageal Strictures (BITES): A Randomized Multi-Center Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07100379
Acronym
BITES
Enrollment
128
Registered
2025-08-03
Start date
2025-10-28
Completion date
2028-06-24
Last updated
2026-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Atresia, Esophageal Atresia With Tracheo-esophageal Fistula, Esophageal Strictures

Keywords

endoscopic balloon dilation, post-surgical correction, esophageal strictures

Brief summary

Esophageal atresia (EA) is one of the most common gastrointestinal congenital anomalies that affects 1 in 2500 to 1 in 4000 live births. It is characterized by abnormal development of the esophagus, which requires surgical intervention to be compatible with life. Surgical repair of EA is associated with risk of developing esophageal strictures or narrowing, which nearly affects 40% of cases. Strictures can be treated using endoscopic balloon dilation, which consists of introducing a catheter with a balloon into the esophagus via endoscopy and positioning it across stricture followed by balloon inflation. The inflated balloon is held in position for a set amount of time with the goal to dilate the narrowed area. At this time there are no pediatric studies comparing difference balloon dilation times and outcomes. Our study's goal is to evaluate balloon dilation inflation time in treating esophageal anastomotic strictures to understand if inflation time is associated with outcome.

Interventions

Endoscopic balloon dilation is a routine procedure in which a catheter with a balloon is introduced into the esophagus to help treat esophageal strictures via endoscope. The catheter is placed directly across the span of the esophageal stricture and the balloon is inflated to pre-determined volume in order to dilate the esophageal stricture. Balloon will remain inflated for either 30 or 180 seconds based on patient's randomization.

Sponsors

Boston Children's Hospital
Lead SponsorOTHER
Children's Hospital of Philadelphia
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with esophageal atresia with and without tracheoesophageal fistula, surgically repaired esophageal atresia, esophageal anastomotic strictures requiring endoscopic balloon dilation, and at least 1 endoscopic balloon dilation for esophageal anastomotic strictures within a 6 month period.

Exclusion criteria

* Patients who need endoscopic incisional therapy to manage anastomotic stricture during their first follow up endoscopy, patients requiring administration of intralesional steroid within 4 weeks of repair, have no follow up endoscopy within 6 months period, have any anastomosis type other than esophago-esophageal (e.g. jejunal or colonic interposition), and/or failure to meet target dilation time.

Design outcomes

Primary

MeasureTime frameDescription
Stricture response to endoscopic balloon dilation6 monthsStudy aims to determine whether the efficacy of endoscopic ballon dilation depends on duration of balloon inflation duration and does this influence the need for repeat endoscopic balloon dilations. Response to dilation will be defined by total number of dilations needed to treat stricture in a 6 month period.

Secondary

MeasureTime frameDescription
Change in esophageal anastomotic diameter6 monthsSecondary outcome measures will include esophageal anastomotic diameter at the conclusion of the study period compared to starting esophageal diameter.

Countries

United States

Contacts

CONTACTJessica Yasuda, MD
Jessica.Yasuda@childrens.harvard.edu617-355-3038
CONTACTJames Orozco, DO
james.orozco@childrens.harvard.edu
PRINCIPAL_INVESTIGATORJessica Yasuda, MD

Boston Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 1, 2026